RHB-104

July 7, 2015July 7, 2015

RedHill Biopharma Authorized to Test RHB-104 for Crohn’s Disease in Australia and New Zealand

Crohn's Disease, News

Israel-based RedHill Biopharma Ltd. recently disclosed it has been granted authorization to begin enrolling patients in Australia and New Zealand for a Phase III clinical trial designed to test RHB-104 as a ... Read more

July 2, 2015July 2, 2015

RedHill Biopharma Issued Key US Patents for Promising Crohn’s Disease Treatment Candidate

Crohn's Disease, News

Israel-based biopharmaceutical company RedHill Biopharma Ltd. recently announced its acquisition of two notices of allowance from the United States Patent and Trademark Office (USPTO) covering patient application numbers 13/722,395 and 14/271,758 for RHB-104, ... Read more

June 17, 2015September 28, 2016

RedHill Announces MHRA Acceptance of Clinical Trial Application for Phase III clinical trial of RHB-104 in Crohn’s Disease

Crohn's Disease, News

RedHill Biopharma Ltd., an emerging biopharmaceutical company based in Israel focused on the development of small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, recently announced that the UK ... Read more

June 4, 2015September 28, 2016

RedHill Releases Update on Promising IBD Therapies

IBD News, News

Israel-based biopharmaceutical company RedHill Biopharma recently released an update on the development of its drug pipeline, including a treatment for Crohn’s disease, and announced key milestones expected by the company for the upcoming period. RedHill ... Read more

May 28, 2015May 28, 2015

RedHill to Present Crohn’s Therapy at Upcoming Conference

Crohn's Disease, News

RedHill Biopharma recently announced in a press release that the company will be hosting a presentation at the upcoming Jefferies 2015 Global Healthcare Conference. Guy Goldberg, RedHill’s chief business officer, will discuss RedHill’s progress in developing late clinical-stage, ... Read more

December 4, 2014December 4, 2014

RedHill Funds Israeli IBD Society Meeting and Presents Crohn’s Study

IBD News, News

The Israeli company RedHill Biopharma Ltd. is sponsoring the Israeli Inflammatory Bowel Disease Society meeting, which is taking place on December 9th at the Dan Hotel in Tel-Aviv, Israel. The company’s role as sponsor ... Read more